Wednesday, October 23, 2019

Alembic Pharma gets USFDA nod for Desonide Ointment

Alembic Pharma gets USFDA nod for Desonide Ointment Desonide Ointment, 0.05 per cent, is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, Alembic Pharmaceuticals sad in a BSE filing.

from Moneycontrol Business News https://ift.tt/31Ja58u
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...